A case of rhabdomiolysis associated with raltegravir use

被引:25
作者
Dori, Luca [1 ]
Buonomini, Anna R. [1 ]
Viscione, Magda [1 ]
Sarmati, Loredana [1 ]
Andreoni, Massimo [1 ]
机构
[1] Univ Roma Tor Vergata, Clin Infect Dis, I-00133 Rome, Italy
关键词
INTEGRASE INHIBITOR; HIV-1; RHABDOMYOLYSIS; INFECTION;
D O I
10.1097/QAD.0b013e328334cc4a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:473 / 475
页数:3
相关论文
共 12 条
[1]   Raltegravir: The First HIV Integrase Inhibitor [J].
Cocohoba, Jennifer ;
Dong, Betty J. .
CLINICAL THERAPEUTICS, 2008, 30 (10) :1747-1765
[2]  
CONNELLY S, 2007, US FOOD DRUG ADM DIV
[3]   Raltegravir A Review of its Use in the Management of HIV Infection in Treatment-Experienced Patients [J].
Croxtall, Jamie D. ;
Keam, Susan J. .
DRUGS, 2009, 69 (08) :1059-1075
[4]   Raltegravir: an integrase inhibitor for HIV-1 [J].
Evering, Teresa H. ;
Markowitz, Martin .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (03) :413-422
[5]   Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals [J].
Markowitz, Martin ;
Morales-Ramirez, Javier O. ;
Nguyen, Bach-Yen ;
Kovacs, Colin M. ;
Steigbigel, Roy T. ;
Cooper, David A. ;
Liporace, Ralph ;
Schwartz, Robert ;
Isaacs, Robin ;
Gilde, Lucinda R. ;
Penning, Larissa ;
Zhao, Jing ;
Teppler, Hedy .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (05) :509-515
[6]  
*MERCK CO INC, 2007, IS PACK INS
[7]   Rhabdomyolysis in an HIV-Infected Patient on Anti-Retroviral Therapy Precipitated by High-Dose Pravastatin [J].
Mikhail, Nasser ;
Iskander, Elizabeth ;
Cope, Dennis .
CURRENT DRUG SAFETY, 2009, 4 (02) :121-122
[8]  
PERAULT MC, 1993, THERAPIE, V48, P487
[9]  
PODSADECKI T, 15 BRIT HIV ASS BHIV
[10]  
STEIGBIGEL R, 16 CIR 2009